Acadian Asset Management
QTTB icon

Acadian Asset Management’s Q32 Bio QTTB Stock Holding History

Acadian Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78M Buy
218,234
+45,648
+26% +$381K ﹤0.01% 983
2026
Q1 		$1.11M Buy
172,586
+124,213
+257% +$590K ﹤0.01% 1126
2025
Q4 		$159K Buy
48,373
+18,634
+63% +$52.7K ﹤0.01% 1581
2025
Q3 		$58K Hold
29,739
– – ﹤0.01% 1621
2025
Q2 		$44K Sell
29,739
-1,399
-4% -$2.38K ﹤0.01% 1500
2025
Q1 		$50K Buy
+31,138
New +$83.8K ﹤0.01% 1439
2024
Q2 		– Sell
-3,695
Closed -$62K – 1919
2024
Q1 		$62K Hold
3,695
– – ﹤0.01% 1356
2023
Q4 		$40K Sell
3,695
-3,530
-49% -$51.6K ﹤0.01% 1487
2023
Q3 		$151K Sell
7,225
-5,722
-44% -$117K ﹤0.01% 1240
2023
Q2 		$205K Sell
12,947
-285
-2% -$5.12K ﹤0.01% 1266
2023
Q1 		$244K Sell
13,232
-436
-3% -$10.9K ﹤0.01% 1219
2022
Q4 		$309K Buy
13,668
+4,851
+55% +$129K ﹤0.01% 1173
2022
Q3 		$255K Buy
8,817
+2,022
+30% +$82.5K ﹤0.01% 1155
2022
Q2 		$241K Buy
6,795
+3,667
+117% +$125K ﹤0.01% 1152
2022
Q1 		$171K Sell
3,128
-1,761
-36% -$109K ﹤0.01% 1247
2021
Q4 		$319K Sell
4,889
-8,012
-62% -$778K ﹤0.01% 1124
2021
Q3 		$1.83M Sell
12,901
-12,943
-50% -$1.65M 0.01% 705
2021
Q2 		$3.38M Buy
+25,844
New +$3.23M 0.01% 566

Other funds holding QTTB

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Acadian Asset Management's QTTB Position: Q2 2026 in Review

Acadian Asset Management increased its Q32 Bio (QTTB) stake by 26% in Q2 2026, buying an estimated $381K and bringing the position to 218,234 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #983.

Acadian Asset Management first reported a position in QTTB in Q2 2021 and has held it in 18 quarters since. The position peaked at $3.38M in Q2 2021. 45 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Acadian Asset Management held 218,234 shares of Q32 Bio worth $2.78M as of Q2 2026.
  • Acadian Asset Management bought 45,648 Q32 Bio shares in Q2 2026, an estimated $381K.
  • Q32 Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #983 holding.
  • Acadian Asset Management first reported a position in Q32 Bio in Q2 2021 and has held it in 18 quarters since.
  • Acadian Asset Management's Q32 Bio position peaked at $3.38M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.